MICB is speculated to contribute to the onset and progression of DN, underscoring its probable significance as a therapeutic target in light of immune dysregulation observed in DN[ 14 , 70 ].
← all excerpts
Identification of novel therapeutic targets for diabetic neuropathy through integrated proteomics and transcriptomics approaches.
1
—
—